Search

everythinglearnresearchcommunity

for

Search:↓

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

PCOS is a major cause of infertility and requires personalized treatment.

Increased PPARGC1α relates to hair thinning in common baldness.

Men with certain types of baldness at age 45 may have a higher risk of colon cancer and colorectal adenoma.

Polycystic Ovary Syndrome (PCOS) often leads to severe acne, and lifestyle changes and hormonal treatments can help manage it.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Hair loss linked to kidney stones in people under 60.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

Targeting androgen receptors in the skin is the most effective treatment for hyperandrogenism-related skin issues.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

Combining modern and Unani treatments may offer better care for hirsutism in PCOS.

Effective PCOS treatments require targeting specific signaling pathways.

Diagnosing and treating PCOS is complex due to differing criteria and requires a team approach.

Proteins like aPKC and PDGF-AA, substances like adenosine and ATP, and adipose-derived stem cells all play important roles in hair growth and health, and could potentially be used to treat hair loss and skin conditions.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Finasteride safely treats enlarged prostate and male-pattern baldness.

New treatments for hair loss are being developed using molecular biology.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Spironolactone plus finasteride reduces hirsutism more effectively.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

The osteopontin gene is active in a specific part of rat hair follicles during a certain hair growth phase and might affect hair cycle and diseases.